High-Quality Bispecific T-Cell Engagers (BiTEs) | Thermo Fisher Services
Unleashing the power of Cell Therapy, T&L Biotechnology Co., Ltd. is proud to introduce our cutting-edge Bispecific T-Cell Engagers (BiTEs) technology. Our BiTEs are designed to redirect T cells to recognize and attack specific cancer cells, offering a promising new avenue for cancer treatment, With our innovative cell therapy approach, we aim to harness the patient's own immune system to target and destroy cancer cells, offering a potentially more precise and effective treatment option. By engineering T cells to express specific BiTEs, we can enhance their ability to recognize and eliminate cancer cells while sparing healthy tissues, Join us in revolutionizing cancer treatment with our groundbreaking Bispecific T-Cell Engagers (BiTEs) technology
- High-Quality Cba (Cord Blood Association)
- CGT Cba (Cord Blood Association)
- Cell therapy Cba (Cord Blood Association)
- Custom Termis (Tissue Engineering And Regenerative Medicine International Society)
- High-Quality Termis (Tissue Engineering And Regenerative Medicine International Society)
- CGT Termis (Tissue Engineering And Regenerative Medicine International Society)
- Cell therapy Termis (Tissue Engineering And Regenerative Medicine International Society)
- Custom Issc (International Society Of Stem Cell Biology)
- High-Quality Issc (International Society Of Stem Cell Biology)
- CGT Issc (International Society Of Stem Cell Biology)